Calder Biosciences, Inc., a next-generation vaccine company, has published an article that debuts and validates the application of Calder's '3D Vaxlock' platform technology. When applied to the Respiratory Syncytial Virus ...
Mar 14, 2024
0
1
The Republic of Congo has recorded its first cases of mpox in several regions, the health ministry said, an indication of how the disease may be spreading across Africa since sexual transmission was first confirmed on the ...
Mar 14, 2024
0
0
Viral infections trigger more cases of intussusception, the common cause of bowel blockages in young children, than previously thought, according to a new study.
Mar 14, 2024
0
0
A newly developed intranasal vaccine candidate helps to clear COVID-19 infections more quickly than controls in pre-clinical testing, according to a recent study. The new vaccine platform relies on a protein scaffold that ...
Mar 13, 2024
0
89
If someone is vaccinated against the measles virus, they likely won't get measles.
Mar 11, 2024
0
4
For the first time since 2021, the Centers for Disease Control and Prevention has updated its COVID isolation guidance.
Mar 6, 2024
0
0
A vaccine against Zika virus is safe and effective when administered both before and during pregnancy, according to new research published in npj Vaccines.
Mar 4, 2024
0
12
A new study from the Texas A&M University School of Public Health found that only 9 percent of older Americans had been vaccinated against respiratory syncytial virus (RSV) prior to this fall and winter, despite the threat ...
Mar 2, 2024
1
59
Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored "dark side" of the neuraminidase (NA) protein ...
Mar 1, 2024
0
50
U.S. flu vaccines are likely to move from quadrivalent to trivalent due to a change in circulating influenza viruses, says a University of Michigan researcher. Currently, all influenza vaccines in the United States are quadrivalent, ...
Feb 29, 2024
0
0
